EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype

Nate Goldfarb iD, Joseph Stanek iD, Joseph Walden, Melissa J Rose, Kathleen Nicol, Anthony Villella, Jennifer Young, Susan Creary iD

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31794 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Nate Goldfarb und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Child Health Equity Outcomes and Research, Nationwide Children's Hospital, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Neutrophils, Duffy Blood-Group System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: National Institutes of Health/National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

While nonpathogenic, the Duffy null phenotype (DN) lowers circulating neutrophils. DN is common among youth with sickle cell disease (SCD), but its implications on absolute neutrophil counts (ANC) and hydroxyurea over time are unclear. Our retrospective review found that all children who were not receiving hydroxyurea had stable ANC through age 9 years, but those with DN had lower mean ANC starting at 6 years of age. Among hydroxyurea users, ANC increased over time, regardless of DN status, suggesting opportunities to optimize hydroxyurea. Future studies of hospitalized and older individuals are needed to further examine DN's impact on people with SCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellNeutrophilsDuffy Blood-Group SystemHumansChildRetrospective StudiesMaleFemaleHydroxyureaLeukocyte CountChild, PreschoolPhenotypeAdolescentFollow-Up StudiesInfantPrognosisAntisickling AgentsReceptors, Cell Surface

Stichwörter der Autor:innen

outcomes researchsickle cell anemiasickle cell disease

Substanzen

Duffy Blood-Group SystemHydroxyureaACKR1 protein, humanAntisickling AgentsReceptors, Cell Surface

Autor:innen und Institutionen

  • Center for Child Health Equity Outcomes and Research, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Division of Pediatric Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
  • Division of Pediatric Hematology Oncology, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Nationwide Children's Hospital Research Institute, Columbus, Ohio, USA.

ORCID-Profile: Nate Goldfarb, Joseph Stanek, Susan Creary

Förderung

  • National Institutes of Health/National Cancer Institute

Zitieren

APA

Goldfarb, N., Stanek, J., Walden, J., Rose, M. J., Nicol, K., Villella, A., Young, J., & Creary, S. (2025). Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31794

Vancouver

Goldfarb N, Stanek J, Walden J, Rose MJ, Nicol K, Villella A, et al. Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31794

BibTeX
@article{Goldfarb2025,
  author = {Goldfarb, Nate and Stanek, Joseph and Walden, Joseph and Rose, Melissa J and Nicol, Kathleen and Villella, Anthony and Young, Jennifer and Creary, Susan},
  title = {Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31794}
}
Kostenlos starten →